Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacterales in critically ill patients with hospital or ventilator-acquired pneumonia
- Resource Type
- Article
- Source
- In
Journal of Critical Care April 2020 56:6-11 - Subject
- Language
- ISSN
- 0883-9441